Quality of life outcomes for patients with metastatic castration-resistant prostate cancer and pretreatment prognostic score.

Mosunmoluwa Oyenuga,Susan Halabi,Abayomi Oyenuga,Sean McSweeney,Alicia K Morgans,Charles J Ryan,Anna Prizment

The Prostate（2023）

引用 0|浏览11

暂无评分

摘要

Chemotherapy-naïve mCRPC patients with poorer Halabi prognostic risk scores have poorer QOL and greater pain intensity and interference at baseline and during follow-up.

查看译文

关键词

clinical trial,health-related quality of life,nomograms,patient-reported outcome,prostate cancer

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要